Olodaterol

Major

Olodaterol Amitriptyline Elavil Explained An increased risk of QT interval prolongation, an increased risk of ventricular arrhythmias and potentiated cardiovascular effects Details Olodaterol Sertraline Explained An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Albuterol Oral Inhalation Accuneb® Explained An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Buprenorphine Belbuca Explained An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Amisulpride Injection Barhemsys An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Arsenic Trioxide Trisenox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Aripiprazole Injection Abilify An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Atenolol Tenormin Explained Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Azithromycin AzaSite An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Acebutolol Sectral® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Alfuzosin UroXatral An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Anagrelide Agrylin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Bedaquiline Sirturo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Betaxolol Betoptic S Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Betaxolol Ophthalmic Betoptic® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Bisoprolol Zebeta® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Chloroquine Aralen® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Clonidine Transdermal Patch Catapres An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Dasatinib Phyrago An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Degarelix Injection Firmagon An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Deutetrabenazine Austedo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Disopyramide Norpace An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Dofetilide Tikosyn An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Dolasetron Anzemet An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Dolasetron Injection Anzemet An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Droxidopa Northera An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Encorafenib Braftovi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Entrectinib Rozlytrek An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Eribulin Injection Halaven An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Esmolol Brevibloc Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Famotidine Calmicid An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Famotidine Injection Calmicid An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Felbamate Felbatol An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Flecainide Tambocor® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Foscarnet Injection Foscavir An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Galantamine Razadyne An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Gemifloxacin Factive An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details